Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and treatment are crucial to prevent irreversible hair loss in Lichen Planopilaris.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Dermoscopy helps diagnose rare GLPLS in males.

COVID-19 vaccines do not increase the risk of alopecia areata.

Early treatment can reverse hair loss from dermal fillers.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.